Synopsis
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Polymyxin B, Sulfate (salt)
2. 1405-20-5
3. Polymixin B Sulphate
4. Ks-1428
5. Pmb
6. Akos025392172
7. Polymyxin B Sulfate, Bacillus Polymyxa
8. M02428
9. Polymyxin B Sulfate (1404-26-8 Free Base)
10. 405p205
Molecular Weight | 1301.6 g/mol |
---|---|
Molecular Formula | C56H100N16O17S |
Hydrogen Bond Donor Count | 20 |
Hydrogen Bond Acceptor Count | 22 |
Rotatable Bond Count | 29 |
Exact Mass | 1300.71730696 g/mol |
Monoisotopic Mass | 1300.71730696 g/mol |
Topological Polar Surface Area | 574 Ų |
Heavy Atom Count | 90 |
Formal Charge | 0 |
Complexity | 2240 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 12 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Polymyxin b sulfate |
Drug Label | Polymyxin B for Injection, USP is one of a group of basic polypeptide antibiotics derived from B polymyxa (B aerosporous). Polymyxin B sulfate is the sulfate salt of Polymyxins B1 and B2, which are produced by the growth of Bacillus polymyxa (Prazmow... |
Active Ingredient | Polymyxin b sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500,000 u base/vial |
Market Status | Prescription |
Company | X Gen Pharms; Xellia Pharms Aps; Fresenius Kabi Usa; Eurohlth Intl |
2 of 2 | |
---|---|
Drug Name | Polymyxin b sulfate |
Drug Label | Polymyxin B for Injection, USP is one of a group of basic polypeptide antibiotics derived from B polymyxa (B aerosporous). Polymyxin B sulfate is the sulfate salt of Polymyxins B1 and B2, which are produced by the growth of Bacillus polymyxa (Prazmow... |
Active Ingredient | Polymyxin b sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500,000 u base/vial |
Market Status | Prescription |
Company | X Gen Pharms; Xellia Pharms Aps; Fresenius Kabi Usa; Eurohlth Intl |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
Dosage Form : Tablet
Grade : Oral
Application : Direct Compression
Excipient Details : DC SIM 100 is a directly compressible simethicone powder used for antacid and anti-gas tablets.
Dosage Form : Tablet
Grade : Oral
Application : Emulsifying Agents
Excipient Details : HDK N20 Pharma is used as a pharmaceutical emulsifying agent in tablets, capsules, syrups, and solutions.
Dosage Form : Suspension
Grade : Oral, Topical
Application : Rheology Modifiers
Excipient Details : HPMC 60HD4000 is used as thickener and viscosity modifier in oral solid, liquid and topical dosage forms.
Dosage Form : Suspension
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Application : Rheology Modifiers
Excipient Details : Silfoam® SE 2 is used as a thickener and a viscosity modifier in liquid and topical dosage forms.
Dosage Form : Ophthalmic Solution
Grade : Topical, Parenteral
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral, Topical
Application : Solubilizers
Excipient Details : Poloxamer 188 is used as a solubilizer, emulsifier, stabilizer in parenteral, OSDs & topical formulations such as creams, gels & lotions.
Pharmacopoeia Ref : ChP/USP/EP
Technical Specs : Oxyethylene unit: 75%-85%, Oxypropylene unit: 25%-30%
Ingredient(s) : Poloxamer 188
Dosage Form : Emulsion
Grade : Topical
Dosage Form : Cream / Lotion / Ointment
Grade : Parenteral, Oral, Topical
Dosage Form : Gel
Grade : Topical
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral, Topical
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral, Topical
Dosage Form : Emulsion
Grade : Oral, Topical
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Application : Parenteral
Excipient Details : Squalene is used as a antioxidant, Influenza vaccine adjuvant, and core ingredient in MF59 emulsions.
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Brand Name : Cholesterol (Plant origin...
Application : Emulsifying Agents
Excipient Details : Cholesterol is used as an emulsifier, solubilizer and surfactant in topical formulations such as cream, lotion and ointments.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Cholesterol Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Application : Thickeners and Stabilizers
Excipient Details : Sucrose is used to stabilize proteins, lipids, carbohydrates, ADCs & vaccines. It is also used as a cryopreservative in cell-based bioprocesses.
Pharmacopoeia Ref : USP NF, EP, JP, ChP
Technical Specs : Low Endotoxin, Low Metals
Ingredient(s) : Sucrose
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Brand Name : Copper Sulphate Pentahydr...
Application : Parenteral
Excipient Details : Used as an essential trace element in cell culture media during upstream. Use for vaccines, recombinant proteins, and antibodies manufacturing.
Pharmacopoeia Ref : On Request
Technical Specs : Technical specification will be discussed after enquiry. Customised packaging (from grams to kilogra...
Ingredient(s) : Copper Sulphate Pentahydrate Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Parenteral
Excipient Details : Also known as Provitamin B5. Used in cell culture media in upstream processes as a precursor for Vitamin B5.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : DL-Pantothenol
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Parenteral
Excipient Details : Used as an antioxidant in cell culture media in upstream, in protein purification in downstream and in Biological formulation.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : L-Ascorbic Acid
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Surfactant & Foaming Agents
Excipient Details : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Poloxamer 188
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Thickeners and Stabilizers
Excipient Details : Used as carbon source in cell cultures in upstream, cryoprotectant and stabilizer in lyophilized formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Saccharose Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Parenteral
Excipient Details : Used as an osmolarity agent in culture media, tonicity adjuster in ophthalmics and parenterals solutions.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Sodium Chloride Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Thickeners and Stabilizers
Excipient Details : Used as a fatty acid in cell culture media in upstream. Also used as an emulsifier and stabilizer in final formulation.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Stearic Acid
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Surfactant & Foaming Agents
Excipient Details : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Tween 20 Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Surfactant & Foaming Agents
Excipient Details : Used as surfactant agent in cell culture media, in protein purification and in injectable formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Tween 80 Excipient
Dosage Form : Inhalation
Grade : Inhalation
Application : Empty Capsules
Excipient Details : ACGCAPS™ GI / HI is available in gelatin and cellulose (HPMC) material options and is designed for optimal performance with DPI formulations and various inhalation devices.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Gelatin, Unspecified
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Brand Name : 2-Phenoxyethanol PhEur
Application : Topical
Excipient Details : A & C's 2-Phenoxyethanol is used as an excipient and meets the EP monograph
Pharmacopoeia Ref : PhEur
Technical Specs : Not Available
Ingredient(s) : 2-Phenoxyethanol Excipient
Dosage Form : Ophthalmic Solution
Grade : Ophthalmic and Nasal
Brand Name : Benzalkonium Chloride
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Benzalkonium chloride excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Application : Parenteral
Excipient Details : A & C's Glycerol is an excipient which meets the USP monograph.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Hydrochloric Acid NF
Application : Parenteral
Excipient Details : A&C's Hydrochloric Acid NF is used as a low pH neutralizing agent for pharmaceutical applications.
Dosage Form : Gel
Grade : Topical, Parenteral
Brand Name : Polyethylene Glycol 400
Application : Topical
Excipient Details : A&C's Polyethylene Glycol 400 USP-NF is a short chain non-ionic surfactant.
Pharmacopoeia Ref : Not Available
Technical Specs : Low Endotoxin
Ingredient(s) : polyethylene glycol
Dosage Form : Tablet
Grade : Topical and Oral
Brand Name : Polyethylene Glycol 400
Application : Controlled & Modified Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : polyethylene glycol
Dosage Form : Capsule
Grade : Oral
Brand Name : Polysorbate 80 NF
Application : Solubilizers
Excipient Details : A & C's Polysorbate 80 is an excipient which meets the NF monograph.
Dosage Form : Cream / Lotion / Ointment
Grade : Topical and Oral
Application : Topical
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Sodium Chloride USP
Application : Parenteral
Excipient Details : A & C's Sodium Chloride is an excipient meeting the USP monograph.
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Application : Topical
Excipient Details : A & C's Squalane is an excipient which meets NF monograph.
Dosage Form : Capsule
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Tablet film coating, binders , main material of plant capsules.
Pharmacopoeia Ref : USP/BP/EP/CP
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Emulsifying Agents
Excipient Details : Glidant; Emulsion Stabilizer; Anti-caking Agent.
Dosage Form : Emulsion
Grade : Not Available
Application : Topical
Excipient Details : Anionic emulsifier and consistency factor combination for creams and lotions, Self emulsifying wax
Pharmacopoeia Ref : Ph. Eur.: Cetostearyl alcohol ...
Technical Specs : Not Available
Ingredient(s) : Cetostearyl Alcohol
Dosage Form : Emulsion
Grade : Not Available
Application : Topical
Excipient Details : Self-emulsifying and consistency building, easy-to-use base for dermatological creams
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Cetostearyl Alcohol
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Solubilizers
Excipient Details : Nonionic solubilizer, emulsifier and co-emulsifier
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Solubilizers
Excipient Details : Nonionic solubilizer, emulsifier and co-emulsifier
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Solubilizers
Excipient Details : Nonionic solubilizer, emulsifier and co-emulsifier
Dosage Form : Tablet
Grade : Not Available
Application : Film Formers & Plasticizers
Excipient Details : Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Propylene Glycol
Dosage Form : Cream / Lotion / Ointment
Grade : Not Available
Application : Topical
Excipient Details : Structure-building consistency factor for semi-solids. Viscosity regulator.
Pharmacopoeia Ref : Ph. Eur., USP-NF: Cetyl alcoho...
Technical Specs : Not Available
Ingredient(s) : Cetyl Alcohol
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : Structure-building consistency factor with dry feel, forms crystalline barrier on skin
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP: Stearic ...
Technical Specs : Not Available
Ingredient(s) : Stearic Acid
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for tablets.
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.
Pharmacopoeia Ref : Ph. Eur., USP/NF and J.P
Technical Specs : Not Available
Ingredient(s) : Lactose
Excipients by Applications
Global Sales Information
Market Place
Reply
04 Oct 2021
Reply
11 Jun 2021
Reply
27 Mar 2021
Reply
06 Mar 2020
Reply
29 May 2019
Reply
21 Feb 2019
Reply
13 Feb 2018
REF. STANDARDS & IMPURITIES
CAS Number : 1405-20-5
Quantity Per Vial : 25 mg
Sale Unit : 1
Order Code : P2400000
Batch No : 6
Price (€) : 79
Storage : +5°C ± 3°C
Polymyxin B Sulfate (200 mg) (COLD SHIPMENT R...
CAS Number :
Quantity Per Vial : 200
Sale Unit : mg
Price : $245.00
Details : Material Origin- Fermentation; USMCA- No; KOR...
Monograph :
Storage :
Code/Batch No : Catalog #1547007 / R104F0
ABOUT THIS PAGE
86
PharmaCompass offers a list of Polymyxin B Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Polymyxin B Sulfate manufacturer or Polymyxin B Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Polymyxin B Sulfate manufacturer or Polymyxin B Sulfate supplier.
PharmaCompass also assists you with knowing the Polymyxin B Sulfate API Price utilized in the formulation of products. Polymyxin B Sulfate API Price is not always fixed or binding as the Polymyxin B Sulfate Price is obtained through a variety of data sources. The Polymyxin B Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Polymyxin B manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Polymyxin B, including repackagers and relabelers. The FDA regulates Polymyxin B manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Polymyxin B API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Polymyxin B manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Polymyxin B supplier is an individual or a company that provides Polymyxin B active pharmaceutical ingredient (API) or Polymyxin B finished formulations upon request. The Polymyxin B suppliers may include Polymyxin B API manufacturers, exporters, distributors and traders.
click here to find a list of Polymyxin B suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Polymyxin B DMF (Drug Master File) is a document detailing the whole manufacturing process of Polymyxin B active pharmaceutical ingredient (API) in detail. Different forms of Polymyxin B DMFs exist exist since differing nations have different regulations, such as Polymyxin B USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Polymyxin B DMF submitted to regulatory agencies in the US is known as a USDMF. Polymyxin B USDMF includes data on Polymyxin B's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Polymyxin B USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Polymyxin B suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Polymyxin B Drug Master File in Japan (Polymyxin B JDMF) empowers Polymyxin B API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Polymyxin B JDMF during the approval evaluation for pharmaceutical products. At the time of Polymyxin B JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Polymyxin B suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Polymyxin B Drug Master File in Korea (Polymyxin B KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Polymyxin B. The MFDS reviews the Polymyxin B KDMF as part of the drug registration process and uses the information provided in the Polymyxin B KDMF to evaluate the safety and efficacy of the drug.
After submitting a Polymyxin B KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Polymyxin B API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Polymyxin B suppliers with KDMF on PharmaCompass.
A Polymyxin B CEP of the European Pharmacopoeia monograph is often referred to as a Polymyxin B Certificate of Suitability (COS). The purpose of a Polymyxin B CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Polymyxin B EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Polymyxin B to their clients by showing that a Polymyxin B CEP has been issued for it. The manufacturer submits a Polymyxin B CEP (COS) as part of the market authorization procedure, and it takes on the role of a Polymyxin B CEP holder for the record. Additionally, the data presented in the Polymyxin B CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Polymyxin B DMF.
A Polymyxin B CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Polymyxin B CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Polymyxin B suppliers with CEP (COS) on PharmaCompass.
A Polymyxin B written confirmation (Polymyxin B WC) is an official document issued by a regulatory agency to a Polymyxin B manufacturer, verifying that the manufacturing facility of a Polymyxin B active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Polymyxin B APIs or Polymyxin B finished pharmaceutical products to another nation, regulatory agencies frequently require a Polymyxin B WC (written confirmation) as part of the regulatory process.
click here to find a list of Polymyxin B suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Polymyxin B as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Polymyxin B API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Polymyxin B as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Polymyxin B and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Polymyxin B NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Polymyxin B suppliers with NDC on PharmaCompass.
Polymyxin B Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Polymyxin B GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Polymyxin B GMP manufacturer or Polymyxin B GMP API supplier for your needs.
A Polymyxin B CoA (Certificate of Analysis) is a formal document that attests to Polymyxin B's compliance with Polymyxin B specifications and serves as a tool for batch-level quality control.
Polymyxin B CoA mostly includes findings from lab analyses of a specific batch. For each Polymyxin B CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Polymyxin B may be tested according to a variety of international standards, such as European Pharmacopoeia (Polymyxin B EP), Polymyxin B JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Polymyxin B USP).